Merck & Co. (MRK)

R&D Expense Growth

-22.43%

Quarterly · Period ending:

MRK logo

MRK R&D Expense Growth

Latest reported-22.43%
MRK Quarterly R&D Growth (QoQ) (0.00% → -22.43%)
High-resolution chart · PNG

MRK r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-22.4319%
402.521%
-29.6453%
0.339%
13.4979%
-31.959%
-21.8014%
67.4857%
-12.3246%
-58.5333%
191.1098%
-75.1745%
211.5295%
13.2715%
-14.185%
57.2194%
8.618%
-16.0365%
25.4806%
-43.4159%
79.1459%
-58.6774%
74.2908%
60.6235%
-5.6134%
-13.3046%
-20.4744%
46.3682%
13.361%
-12.7823%
7.06%
-9.0589%
-28.8486%
40.114%
-48.3118%
147.6431%
-2.623%
-60.6367%
179.387%
-22.6406%
29.6564%
-7.7308%
19.8667%
-10.1796%
-3.8572%
-23.9159%
37.613%
-0.3005%
5.7179%
-14.2234%
10.5422%
-20.99%
10.173%
-14.2536%
15.9541%
-11.4088%
16.2728%
-23.026%
23.7973%
0.9298%
-10.2873%
-52.2249%
94.5306%
6.5626%
6.2409%
4.0325%
57.2169%
-10.1269%
13.9765%
-11.7121%
18.4015%
0.1539%
8.4392%
-21.9641%
-4.075%
39.7865%
0.0485%
-40.2205%
82.2509%
-19.3689%
24.4692%
-15.2878%
17.9716%
-0.4436%
11.8356%
-23.6334%
20.5918%
-6.7647%
-1.0338%
11.3309%
15.2479%
-1.2589%
-2.9974%
-3.35%
23.9179%
7.2402%
19.027%
-25.9771%
21.362%
-2.0086%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.